MANILA — Filipinos battling tuberculosis (TB) will have another way to access prescribed medicines starting November 1, as the Philippine Health Insurance Corporation (PhilHealth) expands its GAMOT program to help bridge gaps in treatment.
Under PhilHealth Circular No. 2026-0018, eligible members and their dependents with confirmed drug-susceptible TB may obtain covered first-line anti-TB medicines from PhilHealth-accredited GAMOT facilities using prescriptions issued by physicians accredited under the Yaman ng Kalusugan Program (YAKAP).
The expanded benefit aims to make essential medicines more accessible and help patients maintain their treatment. Notably, covered anti-TB medicines will not be deducted from the ₱20,000 annual GAMOT benefit limit, preserving the allocation for other eligible outpatient medications.
Patients may receive up to a one-month supply per prescription transaction. Accredited GAMOT facilities must dispense the complete prescribed quantity within two days of prescription issuance. Patients must claim their medicines within the prescribed period or may need to obtain an updated prescription or pay out of pocket.The expanded benefit complements the existing Outpatient TB-DOTS Package, which remains PhilHealth’s primary benefit for comprehensive outpatient TB care.
TB-DOTS facilities will continue providing treatment and medicines when supplies are available and sufficient.However, when first-line anti-TB medicines are dispensed through a GAMOT facility instead of a TB-DOTS facility, an automatic 50% deduction will apply to the TB-DOTS package claim for each treatment phase.
PhilHealth encourages members to consult their YAKAP-authorized physician or TB-DOTS provider to determine the appropriate treatment arrangements and how to access the benefit.Members seeking information about YAKAP registration, physician selection, and clinic locations may contact the PhilHealth Corporate Action Center at (02) 8662-2588.










